A number of clinically significant human diseases are associated with translocations of chromosome 22 at q11, suggesting specificity of this site in chromosomal rearrangement. The disorders include: Supernumerary der(22), t(11;22) syndrome, DiGeorge syndrome, the Phl chromosome of chronic myelogenous leukemia (CML), t(8;22) of Burkitt's lymphoma, 5(11;22) of Ewing's sarcoma, and cat-eye syndrome. We plan to: 1) assign a linear sequence of breakpoints to the derivative 22 chromosome of these disorders by comparative mapping studies using high resolution cytogenetics and in situ hybridization of chromosome 22 specific DNA probes; 2) examine the constancy of the 22q11 breakpoint for the 11;22 translocation in different families, and of the 9;22 rearrangement for different individuals with Phl-positive CML, using restriction enzymes and Southern blot analysis of genomic DNA coupled with in situ hybridization of DNA probes; 3) study the organization of chromosome 22 with regard to a specific gene cluster by examining the role of the immunoglobulin lambda chain genes in these specific rearrangements; 4) clone and examine the DNA sequences adjacent to the breakpoints at 11q23 and 22q11 and compare the constitutional 11;22 translocation with the 11;22 of Ewing's sarcoma, as well as to other 22q11 rearrangements; and 5) select a single copy DNA sequence from the chromosome 22 library that maps proximal to C-lambda and in 22q11.1; identify the origin of the cat-eye chromosome by hybridization of this probe in situ; determine the copy number of this sequence in chromosomal and nonchromosomal DiGeorge syndrome patients by in situ hybridization or quantitative Southern blot analysis. The application of this combined molecular and high resolution cytogenetic approach to chromosome 22 is to gain insight into the relationship between chromosome structure, molecular organization and developmental disorder and will ultimately lead to a better understanding of the molecular basis of chromosomal rearrangement and disease. (6)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA039926-05
Application #
3179292
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1985-01-01
Project End
1990-06-30
Budget Start
1989-01-01
Budget End
1990-06-30
Support Year
5
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Kato, Takema; Franconi, Colleen P; Sheridan, Molly B et al. (2014) Analysis of the t(3;8) of hereditary renal cell carcinoma: a palindrome-mediated translocation. Cancer Genet 207:133-40
Bloch, Mercedes; Leonard, Anissa; Diplas, Andreas A et al. (2014) Further phenotype description, genotype characterization in patients with de novo interstitial deletion on 2p23.2-24.1. Am J Med Genet A 164A:1789-94
Inagaki, Hidehito; Ohye, Tamae; Kogo, Hiroshi et al. (2013) Two sequential cleavage reactions on cruciform DNA structures cause palindrome-mediated chromosomal translocations. Nat Commun 4:1592
Kato, Takema; Kurahashi, Hiroki; Emanuel, Beverly S (2012) Chromosomal translocations and palindromic AT-rich repeats. Curr Opin Genet Dev 22:221-8
Vorstman, J A S; van Daalen, E; Jalali, G R et al. (2011) A double hit implicates DIAPH3 as an autism risk gene. Mol Psychiatry 16:442-51
Kurahashi, H; Inagaki, H; Ohye, T et al. (2010) The constitutional t(11;22): implications for a novel mechanism responsible for gross chromosomal rearrangements. Clin Genet 78:299-309
Ohye, Tamae; Inagaki, Hidehito; Kogo, Hiroshi et al. (2010) Paternal origin of the de novo constitutional t(11;22)(q23;q11). Eur J Hum Genet 18:783-7
Tong, Maoqing; Kato, Takema; Yamada, Kouji et al. (2010) Polymorphisms of the 22q11.2 breakpoint region influence the frequency of de novo constitutional t(11;22)s in sperm. Hum Mol Genet 19:2630-7
Sheridan, Molly B; Kato, Takema; Haldeman-Englert, Chad et al. (2010) A palindrome-mediated recurrent translocation with 3:1 meiotic nondisjunction: the t(8;22)(q24.13;q11.21). Am J Hum Genet 87:209-18
Carter, Melissa T; Barrowman, Nicholas J; St Pierre, Stephanie A et al. (2010) Risk of breast cancer not increased in translocation 11;22 carriers: analysis of 80 pedigrees. Am J Med Genet A 152A:212-4

Showing the most recent 10 out of 92 publications